Patent highlights October-November 2023.


Journal

Pharmaceutical patent analyst
ISSN: 2046-8962
Titre abrégé: Pharm Pat Anal
Pays: England
ID NLM: 101582615

Informations de publication

Date de publication:
2024
Historique:
medline: 26 9 2024
pubmed: 26 9 2024
entrez: 26 9 2024
Statut: ppublish

Résumé

A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.

Identifiants

pubmed: 39324858
doi: 10.1080/20468954.2024.2389765
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-29

Auteurs

Hermann Am Mucke (HA)

H.M. Pharma Consultancy, A-1160, Wien, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH